Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
TNGX | Tango Therapeutics, Inc. | Feb 4, 2025 | 2 | -$25.3K | 4 | Feb 6, 2025 | Chief Financial Officer |
TNGX | Tango Therapeutics, Inc. | Feb 3, 2025 | 2 | $0 | 4 | Feb 5, 2025 | Chief Financial Officer |
UPB | Upstream Bio, Inc. | Oct 10, 2024 | 1 | $0 | 4 | Oct 15, 2024 | Director |
UPB | Upstream Bio, Inc. | Oct 10, 2024 | 0 | $0 | 3 | Oct 10, 2024 | Director |
BPMC | Blueprint Medicines Corp | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
VOR | Vor Biopharma Inc. | May 23, 2024 | 1 | $0 | 4 | May 28, 2024 | Director |
TNGX | Tango Therapeutics, Inc. | Feb 6, 2024 | 2 | -$46.9K | 4 | Feb 8, 2024 | Chief Financial Officer |
TNGX | Tango Therapeutics, Inc. | Feb 1, 2024 | 2 | $0 | 4 | Feb 5, 2024 | Chief Financial Officer |
BPMC | Blueprint Medicines Corp | Jun 21, 2023 | 2 | $0 | 4 | Jun 23, 2023 | Director |
VOR | Vor Biopharma Inc. | May 26, 2023 | 1 | $0 | 4 | Jun 2, 2023 | Director |
TNGX | Tango Therapeutics, Inc. | Mar 1, 2023 | 2 | $0 | 4 | Mar 2, 2023 | Chief Financial Officer |
BPMC | Blueprint Medicines Corp | Jun 21, 2022 | 2 | $0 | 4 | Jun 30, 2022 | Director |
VOR | Vor Biopharma Inc. | Jun 14, 2022 | 1 | $0 | 4 | Jun 16, 2022 | Director |
TNGX | Tango Therapeutics, Inc. | Feb 1, 2022 | 1 | $0 | 4 | Feb 3, 2022 | Chief Financial Officer |
BPMC | Blueprint Medicines Corp | Dec 8, 2021 | 2 | $0 | 4/A | Mar 31, 2022 | Director |
BPMC | Blueprint Medicines Corp | Dec 8, 2021 | 0 | $0 | 3/A | Mar 31, 2022 | Director |
TBIO | Translate Bio, Inc. | Sep 14, 2021 | 4 | $0 | 4 | Sep 14, 2021 | Director |
TNGX | Tango Therapeutics, Inc. | Aug 12, 2021 | 1 | $0 | 4 | Aug 16, 2021 | Chief Financial Officer |
TNGX | Tango Therapeutics, Inc. | Aug 10, 2021 | 0 | $0 | 3 | Aug 12, 2021 | Chief Financial Officer |
TBIO | Translate Bio, Inc. | Jun 16, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |